BioLabs Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • BioLabs's estimated annual revenue is currently $22.6M per year.(i)
  • BioLabs's estimated revenue per employee is $155,000

Employee Data

  • BioLabs has 146 Employees.(i)
  • BioLabs grew their employee count by 8% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$7M4573%N/AN/A
#10
$5.4M353%N/AN/A
Add Company

BioLabs are the premier co-working spaces for life science startups- unique places where you can test, develop and grow your game-changing ideas. As entrepreneurs and investors ourselves, we have first-hand experience with the pain-points biotech start-ups face. Our goal is to change how scientific entrepreneurs do business by building an ecosystem that empowers bioinnovators to grow quickly, while maximizing capital efficiency.

keywords:N/A

N/A

Total Funding

146

Number of Employees

$22.6M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

BioLabs's People

NameTitleEmail/Phone
1
VP, Operations | Client ExperienceReveal Email/Phone
2
VP Strategic PartnershipsReveal Email/Phone
3
Operations ManagerReveal Email/Phone
4
Site Director, Eisai Innovation Center BioLabsReveal Email/Phone
5
Operations and Events SpecialistReveal Email/Phone
6
VP Software and TechnologyReveal Email/Phone
7
Site Director, BioLabs San DiegoReveal Email/Phone
8
VP Laboratory & Facilities OperationsReveal Email/Phone
9
Business Operations & Strategy Director + Head BioLabs PhiladelphiaReveal Email/Phone
10
Founder & PresidentReveal Email/Phone

BioLabs News

2022-04-20 - Virax Biolabs Announces the Appointment of Jason D. Davis as Chief Financial Officer

London, United Kingdom, April 28, 2022 (GLOBE NEWSWIRE) -- Virax Biolabs Group Limited (“Virax” or the “Company”) is pleased to announce the...

2022-04-19 - Creative Biolabs Supplements Novel Single-domain Antibody Development with New Service Lines

Creative Biolabs, one of the leading service providers in the field of single-domain antibody (sdAb) development and downstream engineering,...

2022-03-22 - Analysis | The truth about Hunter Biden and the Ukrainian 'bio labs'

A Russian Defense Ministry official has claimed the president's son financed U.S. labs in Ukraine, and right-leaning media jumped on the...

2019-03-20 - Latest Performance: Cleveland BioLabs (NASDAQ: CBLI)

Cleveland BioLabs trades as part of the biotechnology industry and is in the healthcare sector. The company CEO is Yakov Kogan. Cleveland

2019-03-13 - Can We See Significant Insider Ownership On The Celestial Biolabs

If you want to know who really controls Celestial Biolabs Limited (NSE:CELESTIAL), then you'll have to look at the makeup of its share registry.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$28.3M146-12%$120M
#2
$32.9M1463%N/A
#3
$51M14616%$38.7M
#4
$28.9M14615%N/A
#5
$46.9M1471%N/A

BioLabs Executives


NameTitle
John FreemanChief Financial Officer
Adam MilneChief Operating Officer
Nina DudnikChief Business Officer
Jacob LeichterChief Financial Officer
Johannes FruehaufFounder & President
Susan ChaseVP Business Development
Laura HolbergerVP Strategic Partnerships
Brian WilliamsVP Software and Technolog